Meyka AI API is live for developers.Start building.
Advertisement
Danaher Corporation

Danaher Corporation (DHR) Stock Overview

Explore Danaher Corporation’s financial performance, market position, analyst ratings, and future outlook.

DHRNYSE
HealthcareMedical - Diagnostics & Research
$184.30
$2.34(1.25%)
U.S. Market opens in 47h 37m
Advertisement

Danaher Corporation (DHR)

Meyka AI Score

Z

Key Financials

Market Cap130.5B
P/E Ratio35.33
EPS (TTM)$5.16
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$185.02
3 Months$178.96
1 Year Target$219.51

DHR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Danaher Corporation (DHR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.23, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $219.51.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 35.33 and a market capitalization of 130.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.26%
5-Day Change
1.78%
1-Month Change
5.53%
3-Month Change
-8.77%
6-Month Change
-18.55%
Year-to-Date (YTD) Change
-19.50%
1-Year Change
-4.09%
3-Year Change
-10.82%
5-Year Change
-13.46%
All-Time (Max) Change
30836.19%

Contact Information

202 828 0850
2200 Pennsylvania Avenue, NW, Washington, DC, 20037-1701

Company Facts

61,000 Employees
IPO DateDec 29, 1978
CountryUS
Actively Trading

Frequently Asked Questions